Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson's disease

Movement Disorders

Volumn 18, Issue 8, 2003, Pages 890-897

  Courbon, Frédéric ^a   Brefel Courbon, Christine ^b   Thalamas, Claire ^c   Alibelli, Marie Jeanne ^a   Berry, Isabelle ^a   Montastruc, Jean Louis ^b,d   Rascol, Olivier ^b,c   Senard, Jean Michel ^b,d  

^a CHU RANGUEIL   (France)

^b TOULOUSE UNIVERSITY HOSPITAL   (France)

^c CHU PURPAN   (France)

^d Inst Natl de la Sante et de la R   (France)

Author keywords

Autonomic failure; Cardiac MIBG scintigraphy; Multiple system atrophy; Parkinson's disease

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; ANTIPARKINSON AGENT; DOPA DECARBOXYLASE INHIBITOR; DOPAMINE RECEPTOR STIMULATING AGENT; FLUDROCORTISONE; LEVODOPA; MIDODRINE;

ADRENERGIC SYSTEM; ADULT; AGED; ARTICLE; AUTONOMIC DYSFUNCTION; AUTONOMIC NERVOUS SYSTEM FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DYSAUTONOMIA; EARLY DIAGNOSIS; FEMALE; HEART DENERVATION; HEART DISEASE; HEART LEFT VENTRICLE; HEART MUSCLE; HEART SCINTISCANNING; HUMAN; INTERMETHOD COMPARISON; MALE; MEDIASTINUM; MEDICAL ASSESSMENT; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; PARKINSON DISEASE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SHY DRAGER SYNDROME; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYMPATHETIC NERVE;

3-IODOBENZYLGUANIDINE; ADULT; AGED; AUTONOMIC NERVOUS SYSTEM DISEASES; FEMALE; GANGLIA, SYMPATHETIC; HEART; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; PARKINSON DISEASE; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0042975270     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.10461     Document Type: Article

References (29)

1. Gilman S, Low P, Quinn N, et al. Consensus statement on the diagnosis of multiple system atrophy. American Autonomic Society and American Academy of Neurology. Clin Auton Res 1998; 8:359-362.
2. Senard JM, Rai S, Lapeyre-Mestre M, Brefel C, Rascol O, Rascol A, Montastruc JL. Prevalence of orthostatic hypotension in Parkinson's disease. J Neurol Neurosurg Psychiatry 1997;63:584-589.
3. Senard JM, Valet P, Durrieu G, et al. Adrenergic supersensitivity in parkinsonians with orthostatic hypotension. Eur J Clin Invest 1990;20:613-619.
4. Matthews MR. Autonomic ganglia in multiple system atrophy and pure autonomic failure. In: Bannister R, Mathias CJ, editors. Autonomic failure: a text book of clinical disorders of the autonomic nervous system. New York: Oxford University Press; 1992. p 593-621.
5. Takatsu H, Nagashima K, Murase M, et al. Differentiating Parkinson's disease from multiple-system atrophy by measuring cardiac iodine-123 metaiodobenzylguanidine accumulation. JAMA 2000; 284:44-45.
6. Reinhardt MJ, Jü;ngling FD, Krausse TM, Braune S. Scintigraphy differentiation between two forms of primary dysautonomia early after onset of autonomic dysfunction: value of cardiac and pulmonary iodine-123MIBG uptake. Eur J Nucl Med 2000;27:595-600.
7. Druschky A, Hilz MJ, Platsch G, Radespiel-Tröger, Druschky K, Kuwer T, Neundörfer B. Differentiation of Parkinson's disease and multiple system atrophy in early disease stages by means of I-123-MIBG-SPECT. J Neurol Sci 2000;175:3-12.
8. Braune S, Reinhardt M, Scnitzer R, Riedel A, Lücking CH. Cardiac uptake of [123I]MIBG separates Parkinson's disease from multiple system atrophy. Neurology 1999;53:1020-1025.
9. 123I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease. J Neurol Neurosurg Psychiatry 1999;67:189-194.
10. Satoh A, Serita T, Seto M, et al. Loss of 123I-MIBG uptake by the heart in Parkinson's disease: assessment of cardiac sympathetic denervation and diagnostic value. J Nucl Med 1999;40:371-375.
11. Yoshita M. Differentiation of idiopathic Parkinson's disease from striatonigral degeneration and progressive supranuclear palsy using iodine-123 meta-iodobenzylguanidine myocardia scintigraphy. J Neurol Sci 1998;155:60-67.
12. Gibb WK, Lees AJ. The relevance of the Lewy body to the pathogenesis of the idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988;51:745-752.
13. Hughes AJ, Daniel SE, Lees AJ. Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease. Neurology 2001;57: 1497-1499.
14. Hoehn MM, Yahr MD. Parkinsonism: progression and mortality. Neurology 1976;17:427-442.
15. Solanki KK, Bomanji J, Moyes J, Mather SJ, Trainer PJ, Britton KE. A pharmacological guide to medicines which interfere with the biodistribution of radiolabelled metaiodobenzylguanidine (MIBG). Nucl Med Commun 1992;13:513-521.
16. Imholz BP, Wieling W, Langewouters GJ, Montfrans GA. Continuous finger arterial pressure: utility in the cardiovascular laboratory. Clin Auton Res 1991;1:43-53.
17. Ewing DJ, Martyn CN, Young RJ, Clarke BF. The value of cardiovascular autonomic function tests: 10 years of experience in diabetes. Diabetes Care 1985;8:494-498.
18. Merlet P, Valette H, Dubois-Rande JL, et al. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med 1992;33:471-477.
19. Tsuchimochi S, Tamaka N, Tadamura E, Kawamoto M, Fujita T, Yonekura Y, Konishi J. Age and gender differences in normal myocardial adrenergic neuronal function evaluated by iodine-123-MIBG imaging. J Nucl Med 1995;36:969-974.
20. Langer A, Freeman MR, Josse RD, Amstrong PW. Metaiodobenzylguanidine imaging in diabetes mellitus: assessment of cardiac sympathetic denervation and its relation to autonomic dysfunction and silent myocardial ischemia. J Am Coll Cardiol 1995;25:610-618.
21. Geis WP, Kaye MP. Distribution of sympathetic fibers in the left ventricular epicardial plexus of the dog. Circ Res 1968;23:165-170.
22. Gill JS, Hunter GJ, Gane G, Camm AJ. Heterogeneity of the human myocardial sympathetic innervation: in vivo demonstration by iodine 123-labeled meta-iodobenzylguanidine scintigraphy. Am Heart J 1993;126:390-398.
23. Kobayashi H, Terada S, Kanaya S, Kashikura K, Momose M, Hosoda S, Kusakabe K. Artifactual defect of inferior myocardium on 123I-metaiodobenzylguanidine myocardial SPECT: characteristic findings and preventive method on phantom study. Kaku Igaku 1994;31:359-366.
24. Morozumi T, Kusuoka H, Fukuchi K, et al. Myocardial iodine-123-metaiodobenzylguanidine images and autonomic nerve activity in normal subjects. J Nucl Med 1997;38:49-52.
25. Nakajima K, Bunko H, Taki J, Shimizu M, Muramori A, Hisada K. Quantitative analysis of 123I-metaiodobenzylguanidine (MIBG) uptake in hypertrophic cardiomyopathy. Am Heart J 1990;119: 1329-1337.
26. Yoshita M, Fukumoto Y, Kuroda Y, Ohkoshi N. Sympathetic denervation of myocardium demonstrated by 123I-MIBG scintigraphy in pure progressive autonomic failure. Eur Neurol 1997;38: 291-296.
27. Braune S, Reinhardt M, Bathmann J, Krause T, Lehmann M, Lucking CH. Impaired cardiac uptake of meta-[123I]iodobenzylguanidine in Parkinson's disease with autonomic failure. Acta Neurol Scand 1998;97:307-314.
28. Goldstein DS, Holmes C, Li ST, Bruce S, Metman LV, Cannon RO III. Cardiac sympathetic denervation in Parkinson disease. Ann Intern Med 2000;133:338-347.
29. Takatsu H, Nishida H, Matsuo H, et al. Cardiac sympathetic denervation from the early stage of Parkinson's disease: clinical and experimental studies with radiolabeled MIBG. J Nucl Med 2000;41:71-77.